STRS Ohio’s MBX Biosciences MBX Stock Holding History

STRS Ohio’s Portfolio MBX Stock Details MBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$363K	Buy	6,200 +4,200	+210%	+$263K	﹤0.01%	1382
2026 Q2	$110K	Buy	2,000 +400	+25%	+$14K	﹤0.01%	1842
2026 Q1	$47.8K	Buy	1,600 +900	+129%	+$30.6K	﹤0.01%	1942
2025 Q4	$22.1K	Hold	700	–	–	﹤0.01%	2100
2025 Q3	$12.2K	Hold	700	–	–	﹤0.01%	2144
2025 Q2	$7.99K	Hold	700	–	–	﹤0.01%	2171
2025 Q1	$5.17K	Sell	700 -1,400	-67%	-$14.8K	﹤0.01%	1895
2024 Q4	$38.7K	Buy	+2,100	New	+$44.8K	﹤0.01%	1756

Other funds holding MBX

Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return

Sowell Financial Services North Little Rock, Arkansas $3.12B AUM 22.73% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return

Koa Wealth Management Encinitas, California $154M AUM 13.16% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

STRS Ohio's MBX Position: Q3 2026 in Review

STRS Ohio increased its MBX Biosciences (MBX) stake by 210% in Q3 2026, buying an estimated $263K and bringing the position to 6,200 shares worth $363K. The position accounts for ﹤0.01% of the portfolio, ranked #1382.

STRS Ohio first reported a position in MBX in Q4 2024 and has held it in 8 quarters since. 32 funds tracked by Wall St. Rank hold MBX as of Q3 2026.

STRS Ohio held 6,200 shares of MBX Biosciences worth $363K as of Q3 2026.
STRS Ohio bought 4,200 MBX Biosciences shares in Q3 2026, an estimated $263K.
MBX Biosciences made up ﹤0.01% of STRS Ohio's portfolio in Q3 2026, its #1382 holding.
STRS Ohio first reported a position in MBX Biosciences in Q4 2024 and has held it in 8 quarters since.
32 funds tracked by Wall St. Rank held MBX Biosciences as of Q3 2026.

Based on STRS Ohio's 13F filing for Q3 2026, filed 30 Oct 2026.